These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11256727)

  • 1. Quality of public sector care for schizophrenia in Arkansas.
    Fischer EP; Owen RR
    Ment Health Serv Res; 1999 Dec; 1(4):213-21. PubMed ID: 11256727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia.
    Owen RR; Thrush CR; Hudson TJ; Mallory SR; Fischer EP; Clardy JA; Williams DK
    Int J Qual Health Care; 2002 Jun; 14(3):199-206. PubMed ID: 12108530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
    Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
    Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
    Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
    Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
    Busch AB; Frank RG; Lehman AF
    Arch Gen Psychiatry; 2004 May; 61(5):442-8. PubMed ID: 15123488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmarking treatment of schizophrenia: a comparison of service delivery by the national government and by state and local providers.
    Rosenheck RA; Desai R; Steinwachs D; Lehman A
    J Nerv Ment Dis; 2000 Apr; 188(4):209-16. PubMed ID: 10789997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to conventional and atypical antipsychotics after hospital discharge.
    Diaz E; Neuse E; Sullivan MC; Pearsall HR; Woods SW
    J Clin Psychiatry; 2004 Mar; 65(3):354-60. PubMed ID: 15096075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors.
    Leslie DL; Rosenheck RA
    Med Care; 2001 Sep; 39(9):923-33. PubMed ID: 11502950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
    Leslie DL; Rosenheck RA
    J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
    J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia.
    Alphs L; Mao L; Rodriguez SC; Hulihan J; Starr HL
    J Clin Psychiatry; 2014 Dec; 75(12):1388-93. PubMed ID: 25375367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study.
    Fantini G; Tibaldi G; Rucci P; Gibertoni D; Vezzoli M; Cifarelli L; Tiraferri R; Munizza C
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):299-313. PubMed ID: 27019391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How dosing of ziprasidone in a state hospital system differs from product labeling.
    Citrome L; Jaffe A; Levine J
    J Clin Psychiatry; 2009 Jul; 70(7):975-82. PubMed ID: 19653974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence of schizophrenia pharmacotherapy to published treatment recommendations: patient, facility, and provider predictors.
    Leslie DL; Rosenheck RA
    Schizophr Bull; 2004; 30(3):649-58. PubMed ID: 15631257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.